» Articles » PMID: 15983064

Differential Contributions of Central and Effector Memory T Cells to Recall Responses

Overview
Journal J Exp Med
Date 2005 Jun 29
PMID 15983064
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

Although the absolute number of memory CD8+ T cells established in the spleen following antigen encounter remains stable for many years, the relative capacity of these cells to mediate recall responses is not known. Here we used a dual adoptive transfer approach to demonstrate a progressive increase in the quality of memory T cell pools in terms of their ability to proliferate and accumulate at effector sites in response to secondary pathogen challenge. This temporal increase in efficacy occurred in CD62L lo (effector memory) and CD62L hi (central memory) subpopulations, but was most prominent in the CD62L hi subpopulation. These data indicate that the contribution of effector memory and central memory T cells to the recall response changes substantially over time.

Citing Articles

Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma.

Shoumariyeh K, Csernalabics B, Salimi Alizei E, Reinscheid M, Giese S, Ciminski K Vaccines (Basel). 2024; 12(11).

PMID: 39591152 PMC: 11598869. DOI: 10.3390/vaccines12111249.


Non-Glycosylated SARS-CoV-2 Omicron BA.5 Receptor Binding Domain (RBD) with a Native-like Conformation Induces a Robust Immune Response with Potent Neutralization in a Mouse Model.

Wongnak R, Brindha S, Oba M, Yoshizue T, Islam M, Islam M Molecules. 2024; 29(11).

PMID: 38893549 PMC: 11173568. DOI: 10.3390/molecules29112676.


Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.

Wu L, Park S, Jakobsson H, Shackleton M, Moller A Cancers (Basel). 2024; 16(11).

PMID: 38893071 PMC: 11171058. DOI: 10.3390/cancers16111950.


Role of T cells in cancer immunotherapy: Opportunities and challenges.

Ahmed H, Mahmud A, Siddiquee M, Shahriar A, Biswas P, Shimul M Cancer Pathog Ther. 2024; 1(2):116-126.

PMID: 38328405 PMC: 10846312. DOI: 10.1016/j.cpt.2022.12.002.


FLT3L-induced virtual memory CD8 T cells engage the immune system against tumors.

Tu H, Kung Y, Lim L, Tao J, Hu M, Cheng M J Biomed Sci. 2024; 31(1):19.

PMID: 38287325 PMC: 10826030. DOI: 10.1186/s12929-024-01006-9.


References
1.
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401(6754):708-12. DOI: 10.1038/44385. View

2.
Selin L, Lin M, Kraemer K, Pardoll D, Schneck J, Varga S . Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity. 2000; 11(6):733-42. DOI: 10.1016/s1074-7613(00)80147-8. View

3.
Hogan R, Usherwood E, Zhong W, Roberts A, Dutton R, Harmsen A . Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J Immunol. 2001; 166(3):1813-22. DOI: 10.4049/jimmunol.166.3.1813. View

4.
Hogan R, Zhong W, Usherwood E, Cookenham T, Roberts A, Woodland D . Protection from respiratory virus infections can be mediated by antigen-specific CD4(+) T cells that persist in the lungs. J Exp Med. 2001; 193(8):981-6. PMC: 2193400. DOI: 10.1084/jem.193.8.981. View

5.
Marshall D, Turner S, Belz G, Wingo S, Andreansky S, Sangster M . Measuring the diaspora for virus-specific CD8+ T cells. Proc Natl Acad Sci U S A. 2001; 98(11):6313-8. PMC: 33465. DOI: 10.1073/pnas.101132698. View